Summary
Updated Aug 30, 2026
Weili Dai, is Director of Astrana Health, Inc. (ASTH). 2 SEC Form 4 filings on record going back to 2025, most recently on 12 June 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Weili Dai, has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Weili Dai,'s companies, so these are insiders reporting open-market trades at other companies in the same sector.
- AEROEQUITY GP, LLC - $384.00M of FLY open-market activity in the last 12 months
- Jonathan B. Fairbanks - $355.10M of FLOC open-market activity in the last 12 months
- GIC Private Ltd - $332.55M of SARO open-market activity in the last 12 months
- Amberjack Capital Partners, L.P. - $306.16M of INVX open-market activity in the last 12 months
- INNOVEX CO-INVEST FUND, L.P. - $306.16M of INVX open-market activity in the last 12 months
- Martin E. Franklin - $280.71M of APG open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Weili Dai,?
Weili Dai, is a corporate insider, tracked as Director of Astrana Health, Inc. (ASTH). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Weili Dai, submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Weili Dai,'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Weili Dai, and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
